Literature DB >> 9038709

Induction of murine CD5 expression by v-H-ras.

T R Weichert1, R C Schwartz.   

Abstract

The murine CD5 surface antigen is a frequent marker on B-lineage cell lines produced from bone marrow infected with retroviruses expressing v-H-ras. Since CD5+ B cells cannot be detected in adult murine bone marrow, either the viral targets of transformation are a minor contaminating population of CD5+ B-lineage cells or the v-H-ras oncogene is inducing the expression of CD5 on B-lineage cells not previously expressing this marker. We have found that v-H-ras can induce the expression of CD5 on two CD5+ pre-B-cell lines established from murine bone marrow. This induction correlates with increased steady-state levels of CD5 mRNA. These results present the possibility that CD5 expression may be modulated by specific signalling as well as early lineage commitment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9038709      PMCID: PMC1456719          DOI: 10.1046/j.1365-2567.1997.00133.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  CD5 expression is modulated as the B cell moves through the cell cycle.

Authors:  K H Brooks; Y S Yol; J J Pestka
Journal:  Ann N Y Acad Sci       Date:  1992-05-04       Impact factor: 5.691

2.  Modulation of LFA-1 surface antigen expression by activated H-ras oncogene in EBV-infected human B-lymphoblast cells.

Authors:  K Endo; C H Borer; Y Tsujimoto
Journal:  Oncogene       Date:  1991-08       Impact factor: 9.867

Review 3.  Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens.

Authors:  J A Ledbetter; L A Herzenberg
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

4.  Establishment and characterization of BALB/c lymphoma lines with B cell properties.

Authors:  K J Kim; C Kanellopoulos-Langevin; R M Merwin; D H Sachs; R Asofsky
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

Review 5.  Origin of murine B cell lineages.

Authors:  A B Kantor; L A Herzenberg
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

6.  The B-cell surface protein CD72/Lyb-2 is the ligand for CD5.

Authors:  H Van de Velde; I von Hoegen; W Luo; J R Parnes; K Thielemans
Journal:  Nature       Date:  1991-06-20       Impact factor: 49.962

7.  Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways.

Authors:  Y Z Cong; E Rabin; H H Wortis
Journal:  Int Immunol       Date:  1991-05       Impact factor: 4.823

8.  Evidence for an association between the T cell receptor/CD3 antigen complex and the CD5 antigen in human T lymphocytes.

Authors:  N Osman; S C Ley; M J Crumpton
Journal:  Eur J Immunol       Date:  1992-11       Impact factor: 5.532

9.  CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.

Authors:  K E Burgess; M Yamamoto; K V Prasad; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

10.  An enhancer element responsive to ras and fms signaling pathways is composed of two distinct nuclear factor binding sites.

Authors:  M A Reddy; S J Langer; M S Colman; M C Ostrowski
Journal:  Mol Endocrinol       Date:  1992-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.